.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Merck
Citi
Julphar
McKinsey
Novartis
McKesson
Covington
US Department of Justice
QuintilesIMS

Generated: December 16, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; propranolol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrochlorothiazide; propranolol hydrochloride and what is the scope of hydrochlorothiazide; propranolol hydrochloride patent protection?

Hydrochlorothiazide; propranolol hydrochloride
is the generic ingredient in seven branded drugs marketed by Wyeth Ayerst, Wyeth Pharms Inc, Duramed Pharms Barr, Actavis Elizabeth, Ani Pharms Inc, Ivax Sub Teva Pharms, Mylan, Sandoz, Warner Chilcott, and Watson Labs, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; propranolol hydrochloride. One supplier is listed for this compound.

Summary for hydrochlorothiazide; propranolol hydrochloride

Pharmacology for hydrochlorothiazide; propranolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis ElizabethPROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; propranolol hydrochlorideTABLET;ORAL070851-001May 15, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis ElizabethPROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; propranolol hydrochlorideTABLET;ORAL070852-001May 15, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Duramed Pharms BarrPROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDEhydrochlorothiazide; propranolol hydrochlorideTABLET;ORAL071127-001Mar 2, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Duramed Pharms BarrPROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDEhydrochlorothiazide; propranolol hydrochlorideTABLET;ORAL071126-001Mar 2, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms IncPROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; propranolol hydrochlorideTABLET;ORAL070704-001Oct 1, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms IncINDERIDE-80/25hydrochlorothiazide; propranolol hydrochlorideTABLET;ORAL018031-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth AyerstINDERIDE LA 160/50hydrochlorothiazide; propranolol hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019059-003Jul 3, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms IncPROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; propranolol hydrochlorideTABLET;ORAL072042-001Mar 14, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe
Wyeth AyerstINDERIDE LA 80/50hydrochlorothiazide; propranolol hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019059-001Jul 3, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanPROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; propranolol hydrochlorideTABLET;ORAL070947-001Apr 1, 1987ABRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrochlorothiazide; propranolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth AyerstINDERIDE LA 120/50hydrochlorothiazide; propranolol hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019059-002Jul 3, 1985► Subscribe► Subscribe
Wyeth AyerstINDERIDE LA 80/50hydrochlorothiazide; propranolol hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019059-001Jul 3, 1985► Subscribe► Subscribe
Wyeth AyerstINDERIDE LA 160/50hydrochlorothiazide; propranolol hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019059-003Jul 3, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Healthtrust
Citi
Cipla
Novartis
Chinese Patent Office
Cerilliant
Fish and Richardson
US Army
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot